about
Meningococcal VaccinationsRole of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal diseaseImportance of circulating antibodies in protection against meningococcal diseaseMeningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal diseaseStructural and Kinetic Characterizations of the Polysialic Acid O-Acetyltransferase OatWY from Neisseria meningitidisAn evaluation of emerging vaccines for childhood meningococcal diseaseReview of meningococcal vaccines with updates on immunization in adultsCarriage rate and effects of vaccination after outbreaks of serogroup C meningococcal disease, Brazil, 2010.Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humansMultiplex quantitative PCR for detection of lower respiratory tract infection and meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis1H, 13C and 15N assignment of the C-terminal domain of GNA2132 from Neisseria meningitidisMolecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines.Regulation of the type I protein secretion system by the MisR/MisS two-component system in Neisseria meningitidis.Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y.The role of the exopolyphosphatase PPX in avoidance by Neisseria meningitidis of complement-mediated killing.Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodiesBexsero® chronicle.Phenotypic and genotypic characteristics of Neisseria meningitidis disease-causing strains in Argentina, 2010.Phosphoryl moieties of lipid A from Neisseria meningitidis and N. gonorrhoeae lipooligosaccharides play an important role in activation of both MyD88- and TRIF-dependent TLR4-MD-2 signaling pathwaysPersistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.Molecular characterization of invasive Neisseria meningitidis strains isolated in Chile during 2010-2011Characterization of DsbD in Neisseria meningitidis.A decade of invasive meningococcal disease surveillance in Poland.Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive diseaseRecognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant.Meningococcal glycoconjugate vaccines.Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.Influence of the combination and phase variation status of the haemoglobin receptors HmbR and HpuAB on meningococcal virulence.The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens.A Case-Control Study on the Risk Factors for Meningococcal Disease among Children in GreeceCapsular switching in invasive Neisseria meningitidis, Brazil(1).Structural, Functional, and Immunogenic Insights on Cu,Zn Superoxide Dismutase Pathogenic Virulence Factors from Neisseria meningitidis and Brucella abortus.Characterizing non-hydrolyzing Neisseria meningitidis serogroup A UDP-N-acetylglucosamine (UDP-GlcNAc) 2-epimerase using UDP-N-acetylmannosamine (UDP-ManNAc) and derivativesProspects for eradication of meningococcal diseasePatterns of antigenic diversity and the mechanisms that maintain themImmunoproteomics: the key to discovery of new vaccine antigens against bacterial respiratory infections.The impact of the neisserial DNA uptake sequences on genome evolution and stabilityImmunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2-10-year-old children: results of an open, randomised, controlled study.EpiScanGIS: an online geographic surveillance system for meningococcal disease.Fully Synthetic Self-Adjuvanting α-2,9-Oligosialic Acid Based Conjugate Vaccines against Group C Meningitis.
P2860
Q26752993-76D7B07F-0154-4EFB-AB0E-9AEF77DB3D2DQ26995760-12AF0273-02A0-463A-AFE3-42E63AB74920Q27023516-40C61FA7-966C-4F64-B493-CA800A73EA16Q27028161-A14AD4B7-C1B8-4EE6-8021-F3EDAEF853C0Q27655942-A27C6026-E48B-4FF6-A672-2026F03E9C3DQ28741833-99859EDA-48F8-48BB-AB29-AB0FFEAE68F9Q28828692-C70072AD-FFD2-4A2C-B8E2-74EE90BAC69FQ33577121-2553EC76-7E6A-4FCC-A61F-E97EFC0EC6BEQ33734798-70FDB5D6-B356-425F-BAC9-F325693A1B82Q33762638-5091EEBB-45B8-4A03-BAD8-2632F7B05325Q33820835-12CB80EB-CBA3-4615-A3CF-4DA9E3B2C487Q33913048-7BC28BEE-0305-429D-B329-C82770338217Q33928835-6BE03557-9730-4B6C-81E7-4E5EE1666D50Q34155231-C7D86E2C-F31D-4462-A773-47441EFEC0D8Q34232221-C925A309-B97A-426B-B835-BEDF091A6C10Q34529441-ADE6FD5E-42AD-417E-8448-296C4A4CBDDBQ34562726-7250C21D-FD08-4A5A-BDF7-0531A2964552Q34618580-0AAFDB4A-599B-4B61-B5F0-49E46E7C400EQ34690369-43064EED-77C9-48F5-844C-251DAB4B024AQ34707962-4DC2C50B-2DA6-4A25-9CC3-7BCFA2E7809DQ34776133-44C51FF0-E40B-45F4-9B47-2E3E5572733CQ34939544-AD057CEF-DB59-4D94-8758-E623FD29AD99Q34972731-1F334FBA-9F70-49EE-8177-9B82706EFD15Q35187182-25AD83EA-D93F-42B9-8D07-599DEE5192A8Q35191828-A8599DF5-4809-43FC-9880-52E68E740304Q35194824-87D8C332-3A30-4589-BC8D-DFBC0B0906B2Q35920353-57F23EF9-ADBB-402F-9AA8-4BA2A773F402Q35959773-461A32D2-BB5B-4414-8C0E-15BEDAEB9940Q35989852-7E293CCA-4082-42CD-B205-1A88DD95665CQ36063141-251DAA54-4BA0-41D0-ABED-7D4A358273B2Q36148009-7BB90FDE-FEAF-487D-A56D-3DE41FA102E7Q36297476-6EC88BDE-8058-4EF8-A4B0-85CE3FAA17E3Q36421826-BD4023CE-9430-4F59-925E-B5D4BC328303Q36440358-F5C3B7DE-2281-4F33-B4DC-23D118F6B071Q36671962-E793E16C-591E-40C6-B174-CDC58D717680Q36676050-A1AB0ACB-331C-4415-86BE-12B07A8B9797Q36678612-73C292AB-5991-4435-A33E-28C2149E5B82Q36781534-622F39D7-CA41-4AD5-AEC1-2F3CF4F4E7AFQ36791114-2F3C3ACD-1F9B-4942-9C74-09748404D0E2Q36850638-CD137417-8EF2-43D1-B057-2F496285840F
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Conquering the meningococcus.
@ast
Conquering the meningococcus.
@en
type
label
Conquering the meningococcus.
@ast
Conquering the meningococcus.
@en
prefLabel
Conquering the meningococcus.
@ast
Conquering the meningococcus.
@en
P1476
Conquering the meningococcus.
@en
P2093
David S Stephens
P356
10.1111/J.1574-6976.2006.00051.X
P577
2007-01-01T00:00:00Z